|
|
 |
|
Viewing report
|
|
|
|
Fentanyl - Products, Markets, Strategies and Opportunities
Greystone Associates, Nov 2011
Fentanyl: Products, Markets, Strategies and Opportunities is a comprehensive evaluation and analysis of the products, demand factors and participants providing the driving force behind this evolving segment of the pain management sector.
Evolution in Pain Management Guidelines and Treatment:
As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families.
To address this trend clinicians are increasingly turning to fentanyl, a narcotic analgesic significantly more powerful than morphine that is available in sustained release dosage forms from a number of drug suppliers. Fentanyl has demonstrated effectiveness against breakthrough pain and has become a commonly prescribed pain medication for most forms of cancer. Controlled release formulations that include transdermal patches and transmucosal tablets and lozenges help address the issues of patient safety and prescription narcotic drug abuse. Pipeline products include oral inhaler and next-generation spray devices. Annual growth through 2015 will exceed ten percent on a prescription basis, but will be lower on a revenue basis due to the impact of generics.
Highlights:
- Analyzes and evaluates fentanyl products and development-stage candidates and assesses risks and market potential
- Provides assessments of pain management markets for fentanyl and examines key market and commercialization factors
- Evaluates the impact of economic, technology, and regulatory factors on opioid pain management markets
- Provides market data and forecasts to 2015
- Profiles market sector participants, their product development activities and business strategies
Who and Why Should Buy This Report:
The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, treatment segments, and commercial opportunities for this fast-growing narcotic pain medication.
Provider organization business managers, healthcare administrators and investors will also benefit from this study.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
